Clinical trials
Hemorrhage clinical trials
Below are recruiting hemorrhage clinical trials, each written for real people, not researchers. We’re tracking 369 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07115459Recruiting
Brain Monitoring to Predict Recovery After Acute Brain Injury
This study is testing a new way to predict recovery for people with serious brain injuries in the ICU. It uses continuous brain monitoring to gather more information and help doctors make better treatment decisions.
Changsha, HunanAges 18–80 - NCT07098780RecruitingPhase 4
Tranexamic Acid to Prevent Bleeding in Weight Loss Surgery
This trial tests whether a medicine called tranexamic acid (TXA) can reduce bleeding during weight loss surgery. If you are having a sleeve gastrectomy or mini-gastric bypass, taking TXA may lower your risk of hemorrhagic events.
Karachi, SindhAges 18–60 - NCT07065903Recruiting
Nimodipine variability in aneurysmal subarachnoid hemorrhage
This study looks at how nimodipine, a medicine used to prevent blood vessel spasms after a brain bleed, works in people with aneurysmal subarachnoid hemorrhage. It aims to better understand how the drug behaves in your body, which could help improve treatment.
Richmond, VirginiaAges 18–85 - NCT07054801RecruitingPhase 2
Testing lidocaine and steroids for headache after bleeding stroke
This study tests whether giving two medicines (lidocaine and methylprednisolone) directly into the artery during a routine brain vessel procedure can help relieve headaches caused by a bleeding stroke. It may help find a new treatment for this type of headache.
San Francisco, CaliforniaAges 18 years+ - NCT07053917RecruitingPhase 1
Psilocybin therapy for stroke recovery
This trial tests whether a medicine called psilocybin (a psychedelic compound) can help people who had a stroke more than a year ago. It aims to see if the therapy can improve healing and flexibility in the brain.
Baltimore, MarylandAges 18 years+ - NCT07034924Recruiting
Abdominal tourniquet for severe postpartum bleeding
This trial tests a temporary abdominal tourniquet to stop heavy bleeding after childbirth when standard treatments aren't working. It might help women with severe blood loss avoid more invasive procedures.
ZaporizhzhyaAges 18–50 - NCT07026994RecruitingPhase 2
Colchicine to prevent another brain bleed from CAA
This trial tests if colchicine can reduce the risk of another stroke caused by bleeding in the brain due to a condition called cerebral amyloid angiopathy (CAA). You may qualify if you've recently had a brain bleed from CAA and have certain signs on brain scans.
BeijingAges 55 years+ - NCT06994949RecruitingPhase 1
CSF flow study for babies with hemorrhagic hydrocephalus
This trial looks at how fluid moves in the brain of premature babies with hydrocephalus after bleeding. It uses special imaging to see if the fluid is flowing properly, which could help guide treatment.
Houston, TexasAges Up to 6 months - NCT06999122Recruiting
Testing a new helmet-style brain scanner for stroke bleeding
This trial tests a new type of brain scanner (similar to a helmet) that looks for bleeding in the brain without radiation. It is for people who have had stroke-like symptoms in the last 24 hours and have not yet received treatment.
Los Angeles, CaliforniaAges 22 years+ - NCT04624295RecruitingPhase 4
Aspirin soon after certain bleeding stroke, after clot-busting therapy
This trial studies whether starting aspirin early is safe and helpful for people who, after clot-busting treatment for an ischemic stroke, develop a specific type of small brain bleeding called hemorrhagic infarction. You might benefit if your scan later shows this pattern of bleeding and you are not able to take blood-thinners or aspirin is safe for you.
HangzhouAges Any age - NCT05893407Recruiting
Ultrasound test of brain blood flow in ICU injury
This trial tests whether a contrast-enhanced ultrasound can measure blood flow in the brain of people admitted to the ICU for a sudden brain injury. It may help doctors better assess brain damage and guide care using a bedside imaging method.
ParisAges 18 years+ - NCT06918964Recruiting
Ear nerve stimulation for recent brain bleed
This trial tests a gentle electrical ear stimulation device (taVNS) to see if it helps people recover after a recent brain bleed. It is for adults who had a specific type of bleed within the last 3 days and are generally stable otherwise.
Beijing, Beijing MunicipalityAges 18–80 - NCT06878066RecruitingPhase 3
Clot-busting treatment after stroke while on Factor Xa inhibitor
This trial tests a clot-busting drug (thrombolysis) for people who had a stroke while on a Factor Xa inhibitor blood thinner. It aims to see if the drug can still safely break up the clot and reduce disability.
Aalborg, AalborgAges 18 years+ - NCT06870812Recruiting
Quick removal of brain bleed clot study
This trial tests a rapid procedure to remove a blood clot in the brain after a specific type of stroke. It might help people with a moderate-sized bleed in the front part of the brain if treatment can start within 24 hours.
Birmingham, AlabamaAges 18–70 - NCT06863480RecruitingPhase 1
Trial of tocilizumab for bleeding stroke to prevent later strokes
This trial tests if a drug called tocilizumab (TYENNE) can reduce the risk of delayed strokes after a bleeding stroke from a ruptured aneurysm. It is for adults who had a specific type of brain bleed and need a drain to remove fluid.
Gainesville, FloridaAges 18–89 - NCT06836141Recruiting
Biomarkers for memory decline after brain hemorrhage
This study looks for biological signs that might predict memory problems after a brain bleed, which could help doctors provide better care.
Chicago, IllinoisAges 18–80 - NCT06819657Recruiting
Remote ischemic conditioning after aneurysm surgery
This trial tests a safe, non-invasive treatment called remote ischemic conditioning (using a blood pressure cuff on your leg) to see if it helps brain recovery after aneurysm surgery. It might reduce secondary damage and improve outcomes.
Beijing, Beijing MunicipalityAges 18–80 - NCT05077124Recruiting
CytoSorb safety registry for clot-fighting medicine removal
This registry collects information on people who use CytoSorb to remove clot-fighting medicines from the blood. It’s mainly meant to track safety and how quickly the removal works, which may help improve care for future patients.
GrazAges 18 years+ - NCT06799013RecruitingPhase 1
Testing a new RNA vaccine for Crimean-Congo hemorrhagic fever
This trial is testing an investigational RNA vaccine to see if it is safe and helps your body build immunity against Crimean-Congo hemorrhagic fever, a serious viral disease. The study involves two injections and follow-up visits over several months.
San Antonio, TexasAges 18–64 - NCT06802588Recruiting
Better treatment for non-traumatic brain bleeding
This trial studies how to improve care for patients who come to the emergency room with a brain bleed not caused by injury. The goal is to find better ways to manage recovery and outcomes.
AngersAges 18 years+ - NCT06797752Recruiting
Stellate ganglion block and retina blood flow study
This trial looks at how a nerve block (stellate ganglion block) affects blood flow in the retina. It may help people who already get this block for conditions like complex regional pain syndrome understand eye effects.
Dallas, TexasAges 18 years+ - NCT06799390Recruiting
Ear stimulation after brain bleed
This study tests whether gentle electrical stimulation through the ear (called auricular VNS) can help people recover after a bleed in the upper part of the brain. It aims to reduce inflammation and improve outcomes when started within 48 hours.
St Louis, MissouriAges 18 years+ - NCT06781034Recruiting
MRI appearance of brain bleeds in different small vessel diseases
This study looks at how different types of small blood vessel disease in the brain affect the appearance of a recent brain bleed on MRI. It may help doctors better understand and manage these bleeds.
Nîmes, GardAges 18 years+ - NCT06763055RecruitingPhase 3
Study of two drugs for spontaneous brain bleed recovery
This trial compares two medicines (deferoxamine and colchicine) to see if they can prevent further brain damage after a spontaneous brain bleed (intracerebral hemorrhage). The goal is to improve recovery by reducing inflammation and iron-related damage.
Sydney, New South WalesAges 18–80
Hear when a new Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hemorrhage?
- Yes. Clin2 currently lists 369 recruiting hemorrhage studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hemorrhage trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hemorrhage trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.